2-[4-(5-クロロベンゾチアゾール-2-イル)フェノキシ]-2-メチルプロパン酸 化学特性,用途語,生産方法
説明
MHY908 is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ that increases transcriptional activity of PPARα and PPARγ in a luciferase reporter assay in AC2F rat liver cells when used at a concentration of 5 μM.
In vivo, MHY908 (3 mg/kg per day) reduces serum glucose, triglyceride, and insulin levels and improves hepatic steatosis by reducing hepatic triglyceride levels and lipid droplet accumulation in
db/db mice and 20-month-old rats. It reduces peroxynitrite and COX-2 levels, reactive oxygen species (ROS) production, and Akt phosphorylation in isolated kidney from 20-month-old rats when administered at a dose of 3 mg/kg. MHY908 inhibits mushroom tyrosinase (IC
50 = 8.19 μM). It also inhibits increases in melanin content in α-melanocyte stimulating hormone-induced B16/F10 murine melanoma cells when used at a concentration of 10 μM.
使用
MHY908 is a dual agonist of PPARα and PPARγ.
2-[4-(5-クロロベンゾチアゾール-2-イル)フェノキシ]-2-メチルプロパン酸 上流と下流の製品情報
原材料
準備製品